Skip to content

The effect of different ways of permanent pacemaker lead passing through tricuspid valve on tricuspid regurgitation

The effect of different ways of permanent pacemaker lead passing through tricuspid valve on tricuspid regurgitation

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100045558
Enrollment
Unknown
Registered
2021-04-19
Start date
2021-04-14
Completion date
Unknown
Last updated
2021-11-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arrhythmia

Interventions

Experimental group:The pacemaker lead is bent before crossing the tricuspid valve
Control group:The pacemaker lead is straight across the tricuspid valve

Sponsors

The First Affiliated Hospital of Shantou University Medical College
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. All selected patients meet the permanent pacemaker implantation category I or IIa indications formulated by the American College of Cardiology/American Heart Association (ACC/AHA) in 2008, and this is the first time a pacemaker is implanted in the patient; 2. Preoperative echocardiographic examinations suggest that there is no tricuspid regurgitation or mild tricuspid regurgitation (regurgitation = 18 years old.

Exclusion criteria

Exclusion criteria: 1. Patients with a single-chamber pacemaker or implanted ICD or CRT for pacing at the atrium; 2. The patient has undergone other heart-related operations before implantation, such as valve replacement or repair; 3. The patient has other serious problems Organic heart disease or non-heart disease that affects the shape or function of the heart, such as tricuspid valve depression, extensive myocardial infarction, etc.; 4. Patients with chronic lung disease and connective tissue disease, uremia, life expectancy 90 years old.

Design outcomes

Primary

MeasureTime frame
Tricuspid regurgitation;Electrocardiogram diagnosis;N-terminal B-type natriuretic peptide;

Countries

China

Contacts

Public ContactChen Yequn

The First Affiliated Hospital of Shantou University Medical College

gdcycyq@163.com+86 754 88905620

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 6, 2026